Oncobiologics

1 Duncan Dr
Cranbury, NJ 08512

Outlook Therapeutics is a late clinical-stage biopharmaceutical company focused on developing and introducing the first FDA-approved ophthalmic formulation of bevacizumab for retinal indications.

The company's primary areas of focus include wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and branch retinal vein occlusion (BRVO).

Generated from their website's infomation

Own this business?
See a problem?

You might also like

United StatesNew JerseyCranburyOncobiologics